Price movement over the last 24 hours
American International Group Inc vs Boston Scientific Corporation — how do they compare? American International Group Inc trades at $79.57 (market cap $42.98B), while Boston Scientific Corporation trades at $44.73 (market cap $67.33B). The key difference: Boston Scientific Corporation is the larger of the two by market cap, and American International Group Inc pays a 2.47% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| AIG | BSX | |
|---|---|---|
Market Cap | $42.98B | $67.33B |
Sector | Financials | Health |
52-Week High | $86.59 | $108.14 |
52-Week Low | $71.89 | $42.68 |
Enterprise Value | $50.68B | $76.91B |
Dividend Yield | 2.47% | — |
Signals from Pluang's Aura AI — not financial advice
AIG trades at $81.06, up 2.1% today, showing strong momentum with three consecutive quarterly earnings beats. The stock is supported by bullish technical signals and a consensus price target of $88.13. Recent executive appointments and the acquisition of Everest Colombia signal strategic growth initiatives. Revenue stabilized around $26.8B in 2025 with net income margin improving to 11.88%.
Outlook remains positive with earnings growth and expansion in Latin America offering upside potential. Risks include catastrophe exposure and competitive pressures. Analysts are predominantly neutral with 58.5% Hold ratings, suggesting cautious optimism amid solid fundamentals.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. Its revenue is split roughly evenly between commercial and consumer lines.
Read more on AIG →Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →